Literature DB >> 15655207

Risk factors for estrogen receptor-positive breast cancer.

E Shelley Hwang1, Terri Chew, Stephen Shiboski, Georgianna Farren, Christopher C Benz, Margaret Wrensch.   

Abstract

HYPOTHESIS: Some risk factors associated with breast cancer may be more predictive of estrogen receptor (ER)- positive than ER-negative tumors.
DESIGN: Survey of patients enrolled in a study of breast cancer risk factors.
SETTING: Community population in a northern California county. PATIENTS: A total of 234 individuals diagnosed as having breast cancer between July 1, 1997, and June 30, 1999, reporting Marin County, California, residence and participating in a questionnaire regarding exposure to breast cancer risk factors. MAIN OUTCOME MEASURE: Diagnosis of ER-positive vs ER-negative breast cancer.
RESULTS: Comparison between ER-positive and ER-negative cases showed several factors predictive of ER-positive tumors. In a multivariate model, years of hormone therapy use remained the most significant predictor of ER-positive disease.
CONCLUSIONS: Patients diagnosed as having ER-positive breast cancer were more likely to have undergone hormone therapy. The excess of ER-positive breast cancers reported in Marin County could, therefore, in part, be related to hormone therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15655207     DOI: 10.1001/archsurg.140.1.58

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  7 in total

1.  Breast tumor characteristics in hormone replacement therapy users.

Authors:  Jasmina-Ziva Cerne; Snjezana Frkovic-Grazio; Ksenija Gersak
Journal:  Pathol Oncol Res       Date:  2011-06-16       Impact factor: 3.201

2.  Breast Cancer Incidence and Mortality by Molecular Subtype: Statewide Age and Racial/Ethnic Disparities in New Jersey.

Authors:  Aishwarya Kulkarni; Antoinette M Stroup; Lisa E Paddock; Stephanie M Hill; Jesse J Plascak; Adana A M Llanos
Journal:  Cancer Health Disparities       Date:  2019-08-19

3.  Evidence for Etiologic Subtypes of Breast Cancer in the Carolina Breast Cancer Study.

Authors:  Halei C Benefield; Emily C Zabor; Yue Shan; Emma H Allott; Colin B Begg; Melissa A Troester
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-08-08       Impact factor: 4.254

4.  Recent trends in hormone therapy utilization and breast cancer incidence rates in the high incidence population of Marin County, California.

Authors:  Rochelle R Ereman; Lee Ann Prebil; Mary Mockus; Kathy Koblick; Fern Orenstein; Christopher Benz; Christina A Clarke
Journal:  BMC Public Health       Date:  2010-04-30       Impact factor: 3.295

5.  Race/ethnicity and breast cancer estrogen receptor status: impact of class, missing data, and modeling assumptions.

Authors:  Nancy Krieger; Jarvis T Chen; James H Ware; Afamia Kaddour
Journal:  Cancer Causes Control       Date:  2008-08-14       Impact factor: 2.506

6.  Variants of estrogen-related genes and breast cancer risk in European and African American women.

Authors:  Lei Quan; Chi-Chen Hong; Gary Zirpoli; Michelle R Roberts; Thaer Khoury; Lara E Sucheston-Campbell; Dana H Bovbjerg; Lina Jandorf; Karen Pawlish; Gregory Ciupak; Warren Davis; Elisa V Bandera; Christine B Ambrosone; Song Yao
Journal:  Endocr Relat Cancer       Date:  2014-09-16       Impact factor: 5.678

Review 7.  Estrogen receptors in breast and bone: from virtue of remodeling to vileness of metastasis.

Authors:  I Bado; Z Gugala; S A W Fuqua; X H-F Zhang
Journal:  Oncogene       Date:  2017-04-03       Impact factor: 9.867

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.